| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/20/2001 | CA1341181C Vaccines based on membrane bound proteins and process for making them |
| 02/15/2001 | WO2001011369A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | WO2001011366A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 02/15/2001 | WO2001011335A2 Antiviral compounds that inhibit viral replication |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011085A2 Bdnf polymorphism and association with bipolar disorder |
| 02/15/2001 | WO2001011084A1 Genetic polymorphism in the il-10 promoter |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011066A1 Non-human adenoviral vector for gene transfer, its use and the production thereof |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011063A2 Gene transfer combination vectors, method for the production and utilization thereof |
| 02/15/2001 | WO2001011056A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | WO2001011051A2 Chimeric proteins |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011049A2 Methods and compositions concerning canine interleukin 5 |
| 02/15/2001 | WO2001011048A2 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | WO2001011047A2 Dna sequences isolated from human colonic epithelial cells |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011045A1 A human lactoferrin produced by using an insect cell and method using the same |
| 02/15/2001 | WO2001011043A1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 02/15/2001 | WO2001011042A1 Dapp1, a dual adaptor for phosphotyrosine and 3-phosphoinositides |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001011040A1 Tumor-associated antigen (r11) |
| 02/15/2001 | WO2001011039A2 New sequence variants of the human 1-adrenoreceptor gene and use thereof |
| 02/15/2001 | WO2001011038A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/15/2001 | WO2001011033A2 Identification of genes essential for the survival of haemophilus influenzae through genome scanning by transposition mutagenesis |
| 02/15/2001 | WO2001011032A1 Secretory molecules |
| 02/15/2001 | WO2001011029A1 Transgenic plants expressing photorhabdus toxin |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | WO2001011022A1 Mouse g-protein coupled receptor edg3 |
| 02/15/2001 | WO2001011021A1 Recombinant stabile cell clone, its production and use thereof |
| 02/15/2001 | WO2001011013A2 The interaction of smad6 with hox proteins and uses thereof |
| 02/15/2001 | WO2001011012A2 Human melanoma h11 gene polynucleotides, polypeptides, and methods of use |
| 02/15/2001 | WO2001011010A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 02/15/2001 | WO2001011008A2 Process for obtaining and detecting gram-positive fluorescent bacteria |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010908A1 Ntr3, a member of the tnf-receptor supergene family |
| 02/15/2001 | WO2001010907A2 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | WO2001010906A1 Crystallization and structure determination of staphylococcus aureus elongation factor p |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010903A2 Proteases and protease inhibitors |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010901A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | WO2001010900A2 Globular assembly of amyloid beta protein and uses thereof |
| 02/15/2001 | WO2001010897A2 Methods and compositions for detecting larval taenia solium |
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010892A2 Peptide antagonists of factor viia |
| 02/15/2001 | WO2001010891A2 Il-16 antagonists |
| 02/15/2001 | WO2001010889A1 Rat-g-protein coupled receptor brs3 |
| 02/15/2001 | WO2001010888A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/15/2001 | WO2001010887A2 Multi-functional antimicrobial peptides |
| 02/15/2001 | WO2001010884A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene |
| 02/15/2001 | WO2001010883A1 Cell death gene and uses thereof |
| 02/15/2001 | WO2001010469A2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 02/15/2001 | WO2001010456A2 Peptides that block viral infectivity and methods of use thereof |
| 02/15/2001 | WO2001010448A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 02/15/2001 | WO2001010386A2 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof |
| 02/15/2001 | WO2001010382A2 Compositions and methods related to claudin-7 |
| 02/15/2001 | WO2001010220A2 Insect control system |
| 02/15/2001 | WO2001010205A1 Methods and materials relating to cd39-like polypeptides |
| 02/15/2001 | WO2001010204A1 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 02/15/2001 | WO2001010199A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | WO2000079267A3 Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer |
| 02/15/2001 | WO2000071724A3 Novel compounds from moraxella catarrhalis |
| 02/15/2001 | WO2000071698A3 Mixture for neutralizing enzyme inhibitors |
| 02/15/2001 | WO2000070077A3 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING MURINE ORGANIC ANION TRANSPORTER 5 (mOATP5) AND SCREENING METHODS THEREOF |
| 02/15/2001 | WO2000069900A3 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 02/15/2001 | WO2000069886A3 Oligomeric chaperone proteins |
| 02/15/2001 | WO2000069884A3 Compositions isolated from skin cells and methods for their use |
| 02/15/2001 | WO2000068385A3 Novel nucleic acids and proteins with growth hormone activity |
| 02/15/2001 | WO2000068384A3 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000068370A3 ib00180US MAIS |
| 02/15/2001 | WO2000068264A3 A peptide inhibitor of fibrinogen blood clotting |
| 02/15/2001 | WO2000066067A3 Ibd-associated microbial antigens and methods of using same |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000064946A3 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000059933A3 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
| 02/15/2001 | WO2000058456A3 Compositions and methods for modifying toxic effects of proteinacious compounds |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000053723A8 Scarecrow gene, promoter and uses thereof |
| 02/15/2001 | WO2000053167A3 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 02/15/2001 | WO2000052165A3 Compositions and methods for breast cancer therapy and diagnosis |
| 02/15/2001 | WO2000052137A3 Plant ligand-gated ion channels |
| 02/15/2001 | WO2000049416A3 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000047243A3 Pancreatic ductal trophic factors, uses and composition related thereto |
| 02/15/2001 | WO2000044908A3 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | WO2000039154A8 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 02/15/2001 | WO2000032774A8 12216 receptor, a g-protein coupled receptor |
| 02/15/2001 | WO2000032761A8 Ethylene-response-factor1 (erf1) in plants |
| 02/15/2001 | WO2000011204A3 Homer interacting proteins |
| 02/15/2001 | WO1999057128A8 Optimization of pest resistance genes using dna shuffling |
| 02/15/2001 | DE19937846A1 New human gene BOCT, encoding an organic cation transporter, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/15/2001 | DE19937839A1 New human gene OLFXY, encoding an olfactory receptor, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/15/2001 | DE19936412A1 DNA-Konstrukte zur Herstellung transgener Pflanzen DNA constructs for producing transgenic plants |
| 02/15/2001 | DE19936003A1 Lentivirus aus der Gruppe der Immunschwächeviren der Drillaffen(mandrillus leucophaeus) und ihre Verwendung Lentivirus from the group of immunodeficiency viruses of the drill monkey (mandrillus leucophaeus) and their use |
| 02/15/2001 | DE19908766C2 Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien Use of synthetic Vpr peptides of human immunodeficiency virus type 1 (HIV-1) for the development of therapeutic and diagnostic reagents |